|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US5942496A
(en)
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US6001650A
(en)
|
1995-08-03 |
1999-12-14 |
Avigen, Inc. |
High-efficiency wild-type-free AAV helper functions
|
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
|
AU722624B2
(en)
|
1996-09-06 |
2000-08-10 |
Trustees Of The University Of Pennsylvania, The |
An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase
|
|
US6177403B1
(en)
|
1996-10-21 |
2001-01-23 |
The Trustees Of The University Of Pennsylvania |
Compositions, methods, and apparatus for delivery of a macromolecular assembly to an extravascular tissue of an animal
|
|
US6156303A
(en)
|
1997-06-11 |
2000-12-05 |
University Of Washington |
Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
|
|
DE69933044T3
(de)
|
1998-11-27 |
2016-11-24 |
Ucb Pharma, S.A. |
Zusammensetzungen und verfahren zur erhöhung der knochenmineralisierung
|
|
NZ532635A
(en)
|
2001-11-13 |
2007-05-31 |
Univ Pennsylvania |
A method of identifying unknown adeno-associated virus (AAV) sequences and a kit for the method
|
|
DK2359869T3
(en)
|
2001-12-17 |
2019-04-15 |
Univ Pennsylvania |
Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof
|
|
US7972593B2
(en)
|
2004-06-10 |
2011-07-05 |
Saint Louis University |
Delivery of therapeutic agents to the bone
|
|
JP2008536869A
(ja)
|
2005-04-15 |
2008-09-11 |
プレジデント・アンド・フエローズ・オブ・ハーバード・カレツジ |
Ｋｒｃ活性を調節することによる骨形成および石灰化の調節方法
|
|
US7816140B2
(en)
|
2005-06-14 |
2010-10-19 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Composition and methods for osteogenic gene therapy
|
|
US8859752B2
(en)
|
2006-04-18 |
2014-10-14 |
The Trustees Of The University Of Pennsylvania |
SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)
|
|
US8298818B2
(en)
|
2006-04-28 |
2012-10-30 |
University Of Florida Research Foundation, Inc. |
Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
|
|
US8632797B2
(en)
|
2006-10-31 |
2014-01-21 |
University Of Rochester |
Targeted delivery of therapeutic agents with lyophilized matrices
|
|
US20100113577A1
(en)
|
2007-04-11 |
2010-05-06 |
Bin Shi |
Isolated nucleic acid molecules corresponding to micro rna 145 (mirna-145) and their use in treating colon cancer
|
|
AU2010210600B2
(en)
|
2009-02-06 |
2016-07-14 |
C3 Jian, Inc. |
Calcium-binding agents induce hair growth and/or nail growth
|
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
|
EP2826860B1
(en)
|
2010-04-23 |
2018-08-22 |
University of Massachusetts |
CNS targeting AAV vectors and methods of use thereof
|
|
EP2566566B1
(en)
|
2010-05-03 |
2017-09-06 |
The Texas A&M University System |
Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases
|
|
JP6066912B2
(ja)
|
2010-10-27 |
2017-01-25 |
アムジエン・インコーポレーテツド |
Ｄｋｋ１抗体およびその使用方法
|
|
US9150858B2
(en)
|
2011-08-04 |
2015-10-06 |
Yeda Research And Development Co. Ltd. |
Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
|
|
US20130136729A1
(en)
*
|
2011-11-11 |
2013-05-30 |
University of Virginia Patent Foundation, d/b/a University of Virginia Licensing & Ventures Group |
Compositions and methods for targeting and treating diseases and injuries using adeno-associated virus vectors
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
WO2014005314A1
(zh)
|
2012-07-05 |
2014-01-09 |
香港中文大学 |
基于小核酸药物成骨治疗的骨靶向递送系统及其制备方法
|
|
US10143725B2
(en)
|
2013-03-15 |
2018-12-04 |
Biomet Biologics, Llc |
Treatment of pain using protein solutions
|
|
DE102013111099B4
(de)
|
2013-10-08 |
2023-11-30 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA
|
|
WO2015152183A1
(ja)
|
2014-03-31 |
2015-10-08 |
大日本住友製薬株式会社 |
進行性骨化性線維異形成症の予防剤及び治療剤
|
|
EP3160980B1
(en)
|
2014-05-28 |
2020-05-20 |
The Regents of the University of California |
HYBRID tRNA/pre-miRNA MOLECULES AND METHODS OF USE
|
|
AU2015335923B2
(en)
|
2014-10-21 |
2021-04-29 |
University Of Massachusetts |
Recombinant AAV variants and uses thereof
|
|
CN119876138A
(zh)
|
2014-11-14 |
2025-04-25 |
沃雅戈治疗公司 |
调节性多核苷酸
|
|
CA2968141C
(en)
*
|
2015-01-16 |
2020-08-04 |
Hsing-Mao CHU |
Molecular constructs with targeting and effector elements
|
|
CA3301261A1
(en)
|
2015-01-20 |
2026-03-02 |
Genzyme Corporation |
Analytical ultracentrifugation for characterization of recombinant viral particles
|
|
TN2017000354A1
(en)
|
2015-02-10 |
2019-01-16 |
Genzyme Corp |
VARIANT RNAi
|
|
WO2016131009A1
(en)
|
2015-02-13 |
2016-08-18 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
JP6805174B2
(ja)
*
|
2015-05-12 |
2020-12-23 |
アメリカ合衆国 |
神経成長因子シグナルペプチド及び副甲状腺ホルモンを含むａａｖ分離株及び融合タンパク質
|
|
EP3387151A1
(en)
|
2015-12-10 |
2018-10-17 |
Universität für Bodenkultur Wien |
Compositions and methods for the diagnosis and treatment of bone fractures and disorders
|
|
EP3452101A2
(en)
|
2016-05-04 |
2019-03-13 |
CureVac AG |
Rna encoding a therapeutic protein
|
|
JP2019533003A
(ja)
|
2016-08-11 |
2019-11-14 |
プレシセラ，インコーポレイテッド |
ＴＧＦ−βアンタゴニストコンジュゲート
|
|
WO2018035503A1
(en)
*
|
2016-08-18 |
2018-02-22 |
The Regents Of The University Of California |
Crispr-cas genome engineering via a modular aav delivery system
|
|
JP2020500217A
(ja)
|
2016-10-27 |
2020-01-09 |
セレクセルＳｅｌｅｘｅｌ |
癌治療用の新しい二本鎖オリゴヌクレオチド
|
|
WO2018150271A1
(en)
|
2017-02-17 |
2018-08-23 |
Lonza Ltd. |
Mammalian cells for producing adeno-associated viruses
|
|
AU2019237514A1
(en)
|
2018-03-23 |
2020-10-08 |
University Of Massachusetts |
Gene therapeutics for treating bone disorders
|
|
JP2022520148A
(ja)
|
2018-12-06 |
2022-03-29 |
アークトゥラス・セラピューティクス・インコーポレイテッド |
修飾タンパク質および関連の処置方法
|
|
US12428484B2
(en)
|
2018-12-06 |
2025-09-30 |
Alexion Pharmaceuticals, Inc. |
Anti-ALK2 antibodies and uses thereof
|
|
CN111407758A
(zh)
|
2019-01-08 |
2020-07-14 |
上海中医药大学附属龙华医院 |
斑蝥素作为miR-214-3p/Wnt/β-Catenin信号通路抑制剂防治骨肉瘤的用途
|
|
WO2023283531A2
(en)
|
2021-07-09 |
2023-01-12 |
Dyne Therapeutics, Inc. |
Muscle targeting complexes and uses thereof for modulation of genes associated with muscle health
|
|
CA3163283A1
(en)
|
2020-01-10 |
2021-07-15 |
Romesh R. Subramanian |
Muscle targeting complexes and uses thereof for modulation of genes associated with muscle health
|
|
WO2021202494A1
(en)
|
2020-03-31 |
2021-10-07 |
University Of Massachusetts |
Aav capsids variants and uses thereof
|
|
WO2022040275A1
(en)
|
2020-08-19 |
2022-02-24 |
University Of Massachusetts |
Development of novel gene therapeutics inflammation-induced bone loss
|
|
EP4255457A4
(en)
|
2020-12-03 |
2025-05-21 |
University of Massachusetts |
DEVELOPMENT OF NEW GENE THERAPEUTIC AGENTS FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
|
|
WO2022221581A1
(en)
|
2021-04-15 |
2022-10-20 |
Mammoth Biosciences, Inc. |
Programmable nucleases and methods of use
|